Bacteriophage endolysin Ply113 as a potent antibacterial agent against polymicrobial biofilms formed by and .

Front Microbiol

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.

Published: December 2023

Antibiotic resistance in , , and remains a major public health concern worldwide. Furthermore, these microbes frequently co-exist in biofilm-associated infections, largely nullifying antibiotic-based therapy. Therefore, it is imperative to develop an efficient therapeutic strategy for combating infections caused by polymicrobial biofilms. In this study, we investigated the antibacterial and antibiofilm activity of the bacteriophage endolysin Ply113 . Ply113 exhibited high and rapid lytic activity against , , and , including vancomycin-resistant and methicillin-resistant isolates. Transmission electron microscopy revealed that Ply113 treatment led to the detachment of bacterial cell walls and considerable cell lysis. Ply113 maintained stable lytic activity over a temperature range of 4-45°C, over a pH range of 5.0-8.0, and in the presence of 0-400 mM NaCl. Ply113 treatment effectively eliminated the mono-species biofilms formed by , , and in a dose-dependent manner. Ply113 was also able to eliminate the dual-species biofilms of - and -. Additionally, Ply113 exerted potent antibacterial efficacy , distinctly decreasing the bacterial loads in a murine peritoneal septicemia model. Our findings suggest that the bacteriophage endolysin Ply113 is a promising antimicrobial agent for the treatment of polymicrobial infections.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751913PMC
http://dx.doi.org/10.3389/fmicb.2023.1304932DOI Listing

Publication Analysis

Top Keywords

bacteriophage endolysin
12
endolysin ply113
12
ply113
9
potent antibacterial
8
polymicrobial biofilms
8
biofilms formed
8
lytic activity
8
ply113 treatment
8
ply113 potent
4
antibacterial agent
4

Similar Publications

In vitro and in vivo efficacy studies of an engineered endolysin targeting gram-negative pathogens.

Int J Biol Macromol

January 2025

LyseNTech Co., Ltd., Suite 1002, Innovalley C, 253 Pangyo-Ro, Bundang-Gu, Seongnam, Gyeonggi-Do 13486, Republic of Korea; Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Yong-In, Gyeonggi-Do 17035, Republic of Korea; The Bacteriophage Bank of Korea, Suite 1002, Innovalley C, 253 Pangyo-Ro, Bundang-Gu, Seongnam, Gyeonggi-Do 13486, Republic of Korea. Electronic address:

Endolysins have drawn considerable attention as viable modalities for antibiotic use. The most significant obstacle for Gram-negative targeting endolysins is the presence of the outer membrane barrier. A heterologously expressed endolysin encoded by bacteriophage PBPA90 infecting Pseudomonas aeruginosa exhibited intrinsic antibacterial activity against P.

View Article and Find Full Text PDF

Characterization of the host specificity of the SH3 cell wall binding domain of the staphylococcal phage 88 endolysin.

Arch Microbiol

January 2025

Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, 43400, Malaysia.

Bacteriophages produce endolysins at the end of the lytic cycle, which are crucial for lysing the host cells and releasing virion progeny. This lytic feature allows endolysins to act as effective antimicrobial alternatives when applied exogenously. Staphylococcal endolysins typically possess a modular structure with one or two enzymatically active N-terminal domains (EADs) and a C-terminal cell wall binding domain (CBD).

View Article and Find Full Text PDF

Synergistic Enzybiotic Effect of a Bacteriophage Endolysin and an Engineered Glucose Oxidase Against .

Biomolecules

December 2024

Instituto de Agroquímica y Tecnología de Alimentos, Consejo Superior de Investigaciones Científicas (IATA-CSIC), 46980 Paterna, Valencia, Spain.

represents one of the main risks for food safety worldwide. Two enzyme-based antimicrobials (enzybiotics) have been combined in a novel treatment against this pathogenic bacterium, resulting in a powerful synergistic effect. One of the enzymes is an endolysin from phage vB_LmoS_188 with amidase activity (henceforth A10), and the other is an engineered version of glucose oxidase from (GOX).

View Article and Find Full Text PDF

Characterization of Phage Endolysin PlyDolk21.

Antibiotics (Basel)

January 2025

Department of Food Science and Biotechnology, Research Institute of Food and Biotechnology, Seoul National University of Science and Technology, Seoul 01811, Republic of Korea.

is a significant cause of food poisoning. Broad-spectrum antibiotics, commonly used to control , are becoming less effective due to the rise of antibiotic-resistant strains, necessitating alternative control strategies. A -infecting bacteriophage, Dolk21, and its endolysin, PlyDolk21, were isolated and characterized.

View Article and Find Full Text PDF

Bacterial ghosts (BGs), non-living empty envelopes of bacteria, are produced either through genetic engineering or chemical treatment of bacteria, retaining the shape of their parent cells. BGs are considered vaccine candidates, promising delivery systems, and vaccine adjuvants. The practical use of BGs in vaccine development for humans is limited because of concerns about the preservation of viable bacteria in BGs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!